The End Of A Long Pipeline (2021)

“A new cancer treatment co-developed by associate professor Maged Henary is one of the first Georgia State-based technologies to enter clinical trials.”


Cancer’s silver bullet: the eye behind research (2018)

“Dr. Maged Henary, a Georgia State associate professor of chemistry, is working on new compounds to improve cancer research.”


Georgia State Signs Licensing Agreement With DaZen Theranostics Inc. (2018)

“ATLANTA—Georgia State University has signed a licensing agreement with DaZen Theranostics Inc., a Delaware-based start-up company, to develop a product that can target cancer cells, function as a contrast agent to improve the visibility of cancer cells during diagnostic imaging and deliver a therapeutic drug to destroy cancerous cells.”